Beta-neurotoxic phospholipase A2 (beta-PLA2)

Beta-neurotoxic phospholipase A2-based toxins are a specialized class of presynaptic neurotoxins found in the venoms of Elapidae and Viperidae snakes. These toxins, which include well-known examples like beta-bungarotoxin, crotoxin, and taipoxin, primarily target the presynaptic nerve terminals of the neuromuscular junction. Their mechanism of action involves a combination of high-affinity binding to presynaptic receptors and the enzymatic hydrolysis of membrane phospholipids. This process leads to an initial surge in acetylcholine release followed by a complete and often irreversible depletion of synaptic vesicles, resulting in flaccid paralysis and respiratory failure. Because these toxins cause physical damage to the nerve terminal, they are notoriously difficult to treat with traditional antivenoms once the neurotoxic effects have manifested. Current therapeutic research focuses on small-molecule inhibitors like varespladib, which can rapidly neutralize the enzymatic activity of these toxins and provide a broader window for treatment compared to conventional serotherapy.

Other names

Presynaptic phospholipase A2 neurotoxinBeta-neurotoxinSnake presynaptic phospholipase A2 neurotoxin (SPAN)Beta-bungarotoxinCrotoxinTaipoxinNotexinTextilotoxin

Inhibition of the toxin's enzymatic phospholipase A2 activity and/or blocking its binding to presynaptic receptors, thereby preventing phospholipid hydrolysis and subsequent neurotransmitter release failure.